Metformin and Sulfonylurea Use and Risk of Incident Dementia
- 1 August 2019
- journal article
- research article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 94 (8) , 1444-1456
Abstract
No abstract availableKeywords
Funding Information
- National Institute on Aging (R21 AG055604)
- National Institute on Aging
- National Institute on Aging
- National Institute on Aging
- Health Resources and Services Administration Geriatric Workforce Enhancement Program
- National Institute on Aging
This publication has 31 references indexed in Scilit:
- Metformin attenuates Alzheimer's disease-like neuropathology in obese, leptin-resistant micePharmacology Biochemistry and Behavior, 2012
- Metformin, Other Antidiabetic Drugs, and Risk of Alzheimer's Disease: A Population‐Based Case–Control StudyJournal of the American Geriatrics Society, 2012
- Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signalingProceedings of the National Academy of Sciences, 2010
- Use of Stabilized Inverse Propensity Scores as Weights to Directly Estimate Relative Risk and Its Confidence IntervalsValue in Health, 2010
- Propensity score techniques and the assessment of measured covariate balance to test causal associations in psychological research.Psychological Methods, 2010
- Antidiabetic drug metformin (Glucophage R ) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcriptionProceedings of the National Academy of Sciences, 2009
- Validation of ICD-9-CM coding algorithm for improved identification of hypoglycemia visitsBMC Endocrine Disorders, 2008
- Using Inverse Probability-Weighted Estimators in Comparative Effectiveness Analyses With Observational DatabasesMedical Care, 2007
- Donepezil Improves Cognition and Global Function in Alzheimer DiseaseA 15-Week, Double-blind, Placebo-Controlled StudyArchives of internal medicine (1960), 1998
- The central role of the propensity score in observational studies for causal effectsBiometrika, 1983